跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XPREZA 100 INJECTION 100 MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
XPREZA 100 INJECTION 100 MG/VIAL
Approved
THERAPEUTIC
XPREZA 100 INJECTION 100 MG/VIAL
NATCO PHARMA LIMITED - INDIAPANACEA BIOTEC PHARMA LTD. (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Nov 23, 2016
Approval ID
745635e858292dc5
Company
NATCO PHARMA LIMITED - INDIAPANACEA BIOTEC PHARMA LTD. (INDIA)
Type
Therapeutic
Approval Details
Approval Id
745635e858292dc5
Drug Name
XPREZA 100 INJECTION 100 MG/VIAL
Product Name
XPREZA 100 INJECTION 100 MG/VIAL
Approval Number
SIN15118P
Approval Date
2016-11-23
Registrant
NATCO PHARMA ASIA PTE. LTD.
Licence Holder
NATCO PHARMA ASIA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION
Route Of Administration
SUBCUTANEOUS
Atc Code
L01BC07
Atc Item Name
azacitidine
Pharma Manufacturer Name
NATCO PHARMA ASIA PTE. LTD.
Active Ingredients
Azacitidine
100mg
AZACITIDINE
100 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 23, 2016
Approval ID
745635e858292dc5
Type
Therapeutic
Back to HSA Approvals